Koyfin Home > Directory > Health Care > Amgen Inc > Long-Term Debt / Capital

Amgen Inc Long-Term Debt / Capital Chart (AMGN)

Amgen Inc annual/quarterly Long-Term Debt / Capital from 2010 to 2020.
  • Amgen Inc Long-Term Debt / Capital for the quarter ending June 06, 2020 was $76m a 10.35% increase of 8m year over year
  • Amgen Inc Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $76m a 10.35% increase of 8m year over year
  • Amgen Inc Annual Long-Term Debt / Capital for 2019 was $68m a 6.76% increase of 5m from 2018
  • Amgen Inc Annual Long-Term Debt / Capital for 2018 was $64m a 11.21% increase of 7m from 2017
  • Amgen Inc Annual Long-Term Debt / Capital for 2017 was $56m a 17.02% increase of 10m from 2016
Other Ratios Metrics:
  • Amgen Inc Total Debt / Capital for the quarter ending December 12, 2018 was $73m a 4.94% increase of 4m year over year
  • Amgen Inc Other Liabilities for the quarter ending December 12, 2018 was $10,918m a -7.23% decrease of -789m year over year
  • Amgen Inc Total Debt / Equity for the quarter ending December 12, 2018 was $271m a 16.17% increase of 44m year over year
View Chart On Koyfin

Quarterly AMGN Long-Term Debt / Capital Data

06/2020$76m
03/2020$73m
12/2019$68m
09/2019$68m
06/2019$67m
03/2019$67m
12/2018$64m
09/2018$60m
06/2018$61m
03/2018$65m

Annual AMGN Long-Term Debt / Capital Data

2019$68m
2018$64m
2017$56m
2016$47m
2015$49m
2014$53m
2013$55m
2012$53m
2011$53m
2010$29m